🔎 Trials Near Me

Akèy › Limfòm selil B › Utah › Salt Lake City

Etid klinik pou Limfòm selil B nan Salt Lake City, UT

8 etid pou Limfòm selil B ap chèche patisipan nan sit nan ak bò kote Salt Lake City (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

T-Cell Therapy (EB103) in Adults With Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma (NHL)

Ap rekriteFaz 1/2
  • Intermountain Health, Canyons Region, LDS Hospital, Salt Lake City
Laj 18 ak plis · Tout sèks · Mizajou Oct 1, 2026 · NCT06343311

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

Ap rekriteFaz 1
  • Intermountain Healthcare, Salt Lake City
Laj 18 ak plis · Tout sèks · Mizajou Sep 22, 2026 · NCT07101328

A Study to Investigate Safety and Effectiveness of Tacabrutideg (BGB-16673) in Combination With Other Agents in Participants With Relapsed or Refractory B-Cell Malignancies

Ap rekriteFaz 1/2
  • Huntsman Cancer Institute, Salt Lake City
Laj 18 ak plis · Tout sèks · Mizajou Sep 11, 2026 · NCT06634589

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

Ap rekriteFaz 1/2
  • Huntsman Cancer Institute, Salt Lake City
  • Intermountain Healthcare, Salt Lake City
Laj 18 ak plis · Tout sèks · Mizajou Aug 25, 2026 · NCT05826535

A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy

Ap rekriteFaz 3
  • Intermountain Healthcare, Salt Lake City
Laj 18 ak plis · Tout sèks · Mizajou Aug 4, 2026 · NCT07188558

A Safety and Efficacy Study Evaluating CTX112 in Subjects With Relapsed or Refractory B-Cell Malignancies

Ap rekriteFaz 1/2
  • University of Utah, Salt Lake City
Laj 18 ak plis · Tout sèks · Mizajou Nov 14, 2025 · NCT05643742

Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies

Ap rekriteFaz 1
  • Primary Children's Hospital, Salt Lake City
Laj 1 a 21 · Tout sèks · Mizajou Dec 6, 2024 · NCT05476770

Etid Limfòm selil B nan lòt vil

Lòt etid nan Salt Lake City

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.